The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Inter nation social lockdown versus medical care against COVID-19, a mild environmental insight with special reference to India
Open accessAbstract
Infection by coronavirus (CoV-19) has led to emergence of a pandemic called as Coronavirus Disease (COVID-19) that has so far affected about 210 countries. The dynamic data indicate that the pandemic by CoV-19 so far has infected 2,403,963 individuals, and among these 624,698 have recovered while, it has been fatal for 165,229. Without much experience, currently, the medicines that are clinically being evaluated for COVID-19 include chloroquine, hydroxychloroquine, azithromycin, tocilizumab, lopinavir, ritonavir, tocilizumab and corticosteroids. Therefore, countries such as Italy, USA, Spain and France with the most advanced health care system are partially successful to control CoV-19 infection. India being the 2nd largest populous country, where, the healthcare system is underdeveloped, major portion of population follow unhygienic lifestyle, is able to restrict the rate of both infection and death of its citizens from COVID-19. India has followed an early and a very strict social distancing by lockdown and has issued advisory to clean hands regularly by soap and/or by alcohol based sterilizers. Rolling data on the global index of the CoV infection is 13,306, and the index of some countries such as USA (66,148), Italy (175,055), Spain (210,126), France (83,363) and Switzerland (262,122) is high. The index of India has remained very low (161) so far, mainly due to early implementation of social lockdown, social distancing, and sanitizing hands. However, articles on social lockdown as a preventive measure against COVID-19 in PubMed are scanty. It has been observed that social lockdown has also drastic impacts on the environment especially on reduction of NO2 and CO2 emission. Slow infection rate under strict social distancing will offer time to researchers to come up with exact medicines/vaccines against CoV-19. Therefore, it is concluded that stringent social distancing via lockdown is highly important to control COVID-19 and also to contribute for self-regeneration of nature.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Gautret, P., Lagier, J.-C., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Vieira, V. E., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105949 · Cited by 5,288
RetractedClinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1
van Doremalen, N., Bushmaker, T., Morris, D. H., Holbrook, M. G., Gamble, A., Williamson, B. N., Tamin, A., Harcourt, J. L., Thornburg, N. J., Gerber, S. I., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2004973 · Cited by 9,951
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,958
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001282 · Cited by 5,187
The proximal origin of SARS-CoV-2
Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., & Garry, R. F. (2020) · Nature Medicine · doi:10.1038/s41591-020-0820-9 · Cited by 5,081
Guo (2020) · doi:10.1186/s40779-020-00240-0 · Cited by 4,735
Li, R., Pei, S., Chen, B., Song, Y., Zhang, T., Yang, W., & Shaman, J. (2020) · Science · doi:10.1126/science.abb3221 · Cited by 3,633
COVID-19 infection: Emergence, transmission, and characteristics of human coronaviruses
Shereen, M. A., Khan, S., Kazmi, A., Bashir, N., & Siddique, R. (2020) · Journal of Advanced Research · doi:10.1016/j.jare.2020.03.005 · Cited by 3,536
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
Wang, Q., Zhang, Y., Wu, L., Niu, S., Song, C., Zhang, Z., Lu, G., Qiao, C., Hu, Y., Yuen, K.-Y., et al. (2020) · Cell · doi:10.1016/j.cell.2020.03.045 · Cited by 2,892 · cited 1×
“…et al., 2020; Gordon et al., 2020; Ko et al., 2020; Wang et al., 2020a, 2020b; Wit et al., 2020), tocilizumab, corticosteroids (Loutfy et al., 2003; Smith et al., 2020), certain nucleotide as inhibitors (Elfiky, 2020), COVID-19 protease inhibitors (Liu and Wang, 2020, Table 1) are few to name them.”
Yao, X., Ye, F., Zhang, M., Cui, C., Huang, B., Niu, P., Liu, X., Zhao, L., Dong, E., Song, C., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa237 · Cited by 2,662
Effective treatment of severe COVID-19 patients with tocilizumab
Xu, X., Han, M., Li, T., Sun, W., Wang, D., Fu, B., Zhou, Y., Zheng, X., Yang, Y., Li, X., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005615117 · Cited by 2,647
Gao, J., Tian, Z., & Yang, X. (2020) · BioScience Trends · doi:10.5582/bst.2020.01047 · Cited by 2,590
Peiris, J., Chu, C., Cheng, V., Chan, K., Hung, I., Poon, L., Law, K., Tang, B., Hon, T., Chan, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13412-5 · Cited by 2,375
F. T. Z. H. O. W. U. N. C. M. A. R. T., Jin, Y.-H., Cai, L., Cheng, Z.-S., Cheng, H., Deng, T., Fan, Y.-P., Fang, C., Huang, D., Huang, L.-Q., et al. (2020) · Military Medical Research · doi:10.1186/s40779-020-0233-6 · Cited by 2,254
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.
Caly, L., Druce, J. D., Catton, M. G., Jans, D. A., & Wagstaff, K. M. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104787 · Cited by 2,179
Stability of SARS-CoV-2 in different environmental conditions
Chin, A. W. H., Chu, J. T. S., Perera, M. R. A., Hui, K. P. Y., Yen, H.-L., Chan, M. C. W., Peiris, M., & Poon, L. L. M. (2020) · The Lancet Microbe · doi:10.1016/s2666-5247(20)30003-3 · Cited by 1,946
Molecular immune pathogenesis and diagnosis of COVID-19
Li, X., Geng, M., Peng, Y., Meng, L., & Lu, S. (2020) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2020.03.001 · Cited by 1,721
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings
Chu, C. M. (2004) · Thorax · doi:10.1136/thorax.2003.012658 · Cited by 1,645
Agostini, M. L., Andres, E. L., Sims, A. C., Graham, R. L., Sheahan, T. P., Lu, X., Smith, E. C., Case, J. B., Feng, J. Y., Jordan, R., et al. (2018) · mBio · doi:10.1128/mbio.00221-18 · Cited by 1,416
Discovering drugs to treat coronavirus disease 2019 (COVID-19)
Dong, L., Hu, S., & Gao, J. (2020) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2020.01012 · Cited by 1,390
A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19
Cortegiani, A., Ingoglia, G., Ippolito, M., Giarratano, A., & Einav, S. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.03.005 · Cited by 1,160
Hosts and Sources of Endemic Human Coronaviruses
Corman, V. M., Muth, D., Niemeyer, D., & Drosten, C. (2018) · Advances in Virus Research · doi:10.1016/bs.aivir.2018.01.001 · Cited by 995
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Colson, P., Rolain, J.-M., Lagier, J.-C., Brouqui, P., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105932 · Cited by 937
de Wit, E., Feldmann, F., Cronin, J., Jordan, R., Okumura, A., Thomas, T., Scott, D., Cihlar, T., & Feldmann, H. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1922083117 · Cited by 887
Gordon, C. J., Tchesnokov, E. P., Feng, J. Y., Porter, D. P., & Götte, M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ac120.013056 · Cited by 850
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19
Elfiky, A. A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117477 · Cited by 715
COVID-19: A promising cure for the global panic
Vellingiri, B., Jayaramayya, K., Iyer, M., Narayanasamy, A., Govindasamy, V., Giridharan, B., Ganesan, S., Venugopal, A., Venkatesan, D., Ganesan, H., et al. (2020) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.138277 · Cited by 636
Ashour, H. M., Elkhatib, W. F., Rahman, M. M., & Elshabrawy, H. A. (2020) · Pathogens · doi:10.3390/pathogens9030186 · Cited by 607
Brown, A. J., Won, J. J., Graham, R. L., Dinnon, K. H., Sims, A. C., Feng, J. Y., Cihlar, T., Denison, M. R., Baric, R. S., & Sheahan, T. P. (2019) · Antiviral Research · doi:10.1016/j.antiviral.2019.104541 · Cited by 510
Yao, T., Qian, J., Zhu, W., Wang, Y., & Wang, G. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25729 · Cited by 469
Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines
Liu, X., & Wang, X.-J. (2020) · Journal of Genetics and Genomics · doi:10.1016/j.jgg.2020.02.001 · Cited by 464
2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies
She, J., Jiang, J., Ye, L., Hu, L., Bai, C., & Song, Y. (2020) · Clinical and Translational Medicine · doi:10.1186/s40169-020-00271-z · Cited by 409
MERS coronavirus: diagnostics, epidemiology and transmission
Mackay, I. M., & Arden, K. E. (2015) · Virology Journal · doi:10.1186/s12985-015-0439-5 · Cited by 388
Interferon Alfacon-1 Plus Corticosteroids in Severe Acute Respiratory Syndrome: A Preliminary Study
Loutfy, M. R., Blatt, L. M., Siminovitch, K. A., Ward, S., Wolff, B., Lho, H., Pham, D. H., Deif, H., LaMere, E. A., Chang, M., et al. (2003) · JAMA · doi:10.1001/jama.290.24.3222 · Cited by 381
Arguments in favour of remdesivir for treating SARS-CoV-2 infections
Ko, W.-C., Rolain, J.-M., Lee, N.-Y., Chen, P.-L., Huang, C.-T., Lee, P.-I., & Hsueh, P.-R. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105933 · Cited by 316
The Novel Coronavirus: A Bird's Eye View
Habibzadeh, P., & Stoneman, E. K. (2020) · The International Journal of Occupational and Environmental Medicine · doi:10.15171/ijoem.2020.1921 · Cited by 307
Epigenetic alterations in cancer
Nirmaladevi, R. (2020) · Frontiers in Bioscience · doi:10.2741/4847 · Cited by 289
MERS-CoV: Understanding the Latest Human Coronavirus Threat
Chafekar, A., & Fielding, B. (2018) · Viruses · doi:10.3390/v10020093 · Cited by 276
Woo, P. C. Y., Lau, S. K. P., Lam, C. S. F., Lai, K. K. Y., Huang, Y., Lee, P., Luk, G. S. M., Dyrting, K. C., Chan, K.-H., & Yuen, K.-Y. (2009) · Journal of Virology · doi:10.1128/jvi.01977-08 · Cited by 257
V(D)J Recombination: Mechanism, Errors, and Fidelity
Roth, D. B. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.mdna3-0041-2014 · Cited by 237
Chainy, G. B. N., Paital, B., & Dandapat, J. (2016) · Scientifica · doi:10.1155/2016/6126570 · Cited by 172
Self-citationKumar, R., & Pal, R. (2018) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_218_18 · Cited by 170
Giraud‐Billoud, M., Rivera‐Ingraham, G. A., Moreira, D. C., Burmester, T., Castro‐Vazquez, A., Carvajalino-Fernández, J. M., Dafré, A. L., Niu, C., Tremblay, N., Paital, B., et al. (2019) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2019.04.004 · Cited by 152
Self-citationMacrolides in critically ill patients with Middle East Respiratory Syndrome
Arabi, Y. M., Deeb, A., Al-Hameed, F. M., et al. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.01.041 · Cited by 122
Mishra, P., Paital, B., Jena, S., Swain, S. S., Kumar, S., Yadav, M. K., Chainy, G. B. N., & Samanta, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-43320-5 · Cited by 109
Self-citationPaital, B., Panda, S. K., Hati, A. K., Mohanty, B., Mohapatra, M. K., Kanungo, S., & Chainy, G. B. N. (2016) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v7.i1.110 · Cited by 94
Self-citationSARS-like virus in the Middle East: A truly bat-related coronavirus causing human diseases
Lu, G., & Liu, D. (2012) · Protein & Cell · doi:10.1007/s13238-012-2811-1 · Cited by 79
Geographical structure of bat SARS-related coronaviruses
Yu, P., Hu, B., Shi, Z., & Cui, J. (2019) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2019.02.001 · Cited by 55
microRNAs Epigenetic players in cancer and aging
Nirmaladevi, R. (2019) · Frontiers in Bioscience-Scholar · doi:10.2741/s525 · Cited by 35
The health impact of residential retreats: a systematic review
Naidoo, D., Schembri, A. J., & Cohen, M. M. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-2078-4 · Cited by 33
1.3 billion people. A 21-day lockdown. Can India curb the coronavirus?
(2020) · AAAS Articles DO Group · doi:10.1126/science.abc0030 · Cited by 29
Paital, B., Kumar, S., Farmer, R., & Chainy, G. B. N. (2013) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-013-0150-4 · Cited by 21
Self-citation
Cited by
Abbas, J., Wang, D., Su, Z., & Ziapour, A. (2021) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s284313 · Cited by 365
Prasetyo, Y. T., Castillo, A. M., Salonga, L. J., Sia, J. A., & Seneta, J. A. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.07.074 · Cited by 357
COVID-19 and the environment: A critical review and research agenda
Shakil, M. H., Munim, Z. H., Tasnia, M., & Sarowar, S. (2020) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.141022 · Cited by 313
The Impact of COVID-19 Pandemic on the Academic Performance of Veterinary Medical Students
Mahdy, M. A. A. (2020) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.594261 · Cited by 286
Metadata
- Authors
- Paital, B., Das, K., & Parida, S. K.
- Venue
- Science of The Total Environment
- Publisher
- Elsevier BV
- Published
- 2020-08
- Volume
- 728
- Pages
- 138914
- ISSN
- 0048-9697 (ISSN-L)
- OpenAlex
- W3019692080
- Cited by
- 281
- References
- 54
- FWCI
- 23.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.